Tyrosine kinase signalling in breast cancer. Tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer

Breast Cancer Research

Volumn 2, Issue 3, 2000, Pages 211-216

  Andrechek, E R ^a   Muller, W J ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Mammary gland; Oncogene; Signal transduction; Transgenic mouse

Indexed keywords

GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; RAS PROTEIN; VIRUS T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; HUMAN; METASTASIS; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE NEU; POLYOMA VIRUS; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENES; RAS PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANS-ACTIVATION (GENETICS);

EID: 0034468122     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr56     Document Type: Review

References (68)

1. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer
2. Human breast cancer: Correlation of relapse and survival with the amplification of the HER2/neu oncogene
3. Studies of the HER-2/neu proto-oncogene in human breast and ovaian cancer
4. Activated neu induces rapid tumor progression
5. Early and multifocal tumors in breast, salivary, harderian and epididymal tissues developed in MMTY-Neu transgenic mice
6. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
7. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: Implications for human breast cancer
8. Absence of activating transmembrane mutations in the c-erbB-2 protooncogene in human breast cancer
9. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease
10. Identification of c-erbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using an EGF receptor/c-erbB-3 chimera
11. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor
12. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
13. Evidence of a role for phosphatidylinositol 3-kinase activation in the blocking of apoptosis by polyomavirus middle T antigen
14. PI3K: Downstream AKTion blocks apoptosis
15. Requirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis
16. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease
17. Protein modules and signalling networks
18. Peptide antibodies to the human c-fyn gene product demonstrate pp59c-fyn is capable of complex formation with the middle-T antigen of polyomavirus
19. The complex of polyoma virus middle-T antigen and pp60c-src
20. Association of the polyomavirus middle-T antigen with c-yes protein
21. Identification and characterization of p59fyn (a src-like protein tyrosine kinase) in normal and polyoma virus transformed cells
22. Involvement of pp6Oc-src with two major signaling pathways in human breast cancer
23. Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases
24. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo
25. Activation of the Src family of tyrosine kinases in mammary tumorigenesis
26. Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor
27. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity
28. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice
29. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia
30. An 81 kd protein complexed with middle T antigen and pp60c-src: A possible phosphatidylinositol kinase
31. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): Structural and functional homology with the Drosophila DSTPK61 kinase
32. Akt activation by growth factors is a multiple-step process: The role of the PH domain
33. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase
34. Cellular protection mechanisms against extracellular heme. Heme- hemopexin, but not free heme, activates the N-terminal c-jun kinase
35. Induction of NF-kappaB by the Akt/PKB kinase
36. Activation of phosphatidylinositol 3-kinase in response to interleukin- 1 leads to phosphorylation and activation of the NF-kappaB p65/ReIA subunit
37. Regulation of cell death protease caspase-9 by phosphorylation
38. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
39. Microcirculation and metastasis in a new mouse mammary tumor model system
40. A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway
41. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation
42. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen
43. Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation
44. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc
45. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras
46. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2
47. Structural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7
48. Reconstitution of mammary gland development in vitro: Requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis
49. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction
50. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase
51. Human Sos1: A guanine nucleotide exchange factor for Ras that binds to GRB2
52. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation
53. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling
54. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling
55. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1
56. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases
57. Dominant-negative mutants of Grb2 induced reversal of the transformed phenotypes caused by the point mutation-activated rat HER-2/Neu
58. Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation
59. raIGDS family members interact with the effector loop of ras p21
60. Ras effectors
61. Regulation of ras p21 by GTPase activating proteins
62. Phosphatidylinositol 3′ kinase: One of the effectors of Ras
63. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-0-tetradecanoylphorbol-13- acetate requires Raf and is necessary for transformation
64. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro
65. Activation of phosphoinositide 3-kinase activity by Cdc42Hs binding to p85
66. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo
67. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation
68. Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein